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Abstract.  Malaria is a life-threatening disease due to the development of resistance by the most lethal causative 
parasitic species mainly Plasmodium falciparum. One of a great challenges in malaria controlling program is 
P.falciparum that has been resistant to the most commonly available antimalarials. New drugs with specific 
structures and mode of actions are urgently required to treat sensitive and drug-resistant strains of malaria 
parasites. This study was designed to know the antimalarial activity of the extract of the neem leaves (Azadirachta 
indica A.Juss) on the growth stages of P. falciparum FCR-3. The experimental laboratoric study used “post-test 
only with control design”. RPMI 1640 used as culture medium for cultivation of P. falciparum. Treated drug was the 
extract of neem leaves dissolved in dimethylsulfooxide and prepared into 7 levels concentration (3,125; 6,25; 
12,5; 25; 50; 100 and 200 ug/mL). Negative control was culture medium with the malarial parasites. After 
cultured, synchronized, micromalarial culture were divided into control and treated groups then  incubated in CO2 
Candle Jar at 370 C for 72 hour. Each 8 hour the percentage of parasitemia were measured for observing the 
activity of the extract on the growth stages of P. falciparum. After incubation, supernatant fluid was removed 
without disturbing the erythrocyte layer. Parasitemia was calculated by made the thin blood smear from the 
erythrocyte layer and stained with 10% Giemsa for 30 minutes. The antimalarial activity of the extract was 
calculated by counted the fifty percent of growth inhibition 50 (IC50) using probit analysis. The result showed that 
the neem leaves extract can inhibit the growth of P. falciparum FCR-3 on mature schizont stage and the fifty 
percent inhibitory concentration (IC50) of the extract was 3,86 µg/ml after 32 hour incubating. The result indicated 
that the extract has an antimalarial activity on P. falciparum FCR-3 in vitro. 
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Introduction. The spread of malaria as the major global health problem, the progressive 
drug resistance and limited number of effective drug available have underlined the 
importance of new antimalarial drugs discovery. According to the World Health Organization 
(WHO), in 2008 there were approximately 247 million cases of malaria, causing nearly one 
million deaths, mostly among young children in Africa. Although malaria is preventable and 
curable, it is estimated that in Africa, a child dies every 45 seconds caused by the disease. 
Malaria represents the most serious infection that cause the increasing morbidity and 
mortality in the disease therefore the solution have to be serious to manage it. 
Indonesia health departement (2010) reported in 2008 there were 544.470 cases of 
clinical malaria in Indonesia, 1.100.000 cases in 2009 and in 2010 increased to be 
1.800.000 cases. In any area of Indonesia, the prevalence of malaria in pregnant women is 
18%, so the prediction of babies were born with low body weight risk is two fold greater 
than pregnant women without malaria.The disease affects humans health especially in the 
pregnant women, geriatric with complicated diseases,  breast feeding mothers, babies and 
children. In social economic perspective malarial affects the productivity, income of 
individual and public expenditure.  
Malaria infection is transmitted via the bite of an infected female mosquitoes of 
genus Anopheles. Mosquitoes have been infected through a previous blood meal taken on 
infected human. Infection mosquito caused by the protozoan parasites of the genus 
Plasmodium and  the species of them can produce malaria in human. Four species of 
malarial parasites are P. falciparum, P. vivax, P. ovale and P. malariae. Among them P. 
falciparum is the most widespread and the dangerous parasite, it can causes severe 
anemia, kidney failure, hypoglycaemia and brain damage especially in among children and 
babies (Sutanto, et al., 2008). The great problems in malaria control programmes are 
parasite resistance to the most commercially available antimalarial, and vector mosquitoes 
resistance to insectisides.  
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The increasing global spread of malarial parasites that resistant to the most 
available and affordable antimalarial drugs is a great challenge which  requires innovative 
strategies to combat. This situation  has stimulated research for new drugs active against 
multidrug-resistant P. falciparum parasites. Intensive efforts have been underway for 
decades to produce vaccines which can enhance levels of protective individual immunity. 
However chemoprophylaxis and chemotherapy still play the central role in combating 
malaria infections. Discovery a new antimalarial drugs, preferably with radically different 
structures and mode of action are urgently required to treat sensitive and resistant strains 
of malaria to decrease the morbidity and mortality rate. 
Traditional medicines are potential rich source of new drugs against malaria and the 
investigation of the chemical components of traditional medicinal plants could lead to the 
development of new efficacious antimalarial drugs.  In addition the chemical component 
could be modificated to get potential and safe antimalarial drugs. Pharmacologycal and 
chemistry approaches are needed to use these chemical components as templates for 
designing new derivates with improved properties. Searching for continueous antimalarial 
drugs from plants source must be done to combat the malarial problems in the future. 
In this regard, we show the neem leaves (Azadirachta indica A. Juss), in the 
Meliaceae family, as a unique plant species. It has been used for treatment of fever, 
malaria, as antiinflammatory, antidiabetic, analgetic, antihypertension and hepatoprotector 
(Lewis and Lewis, 1977). The other references reported that the neem leaves can be used 
as antipyretic, antiarthritic, antimalarial, antiseptic, insecticide, antifungal, antioxidant, 
anthelmentic  and anticancer (Perry, 1980;  Sofowara, 1982; Ntalli et al., 2010; Connoly 
and Hill, 2003). Many biologically active compounds can be extracted from neem leaves 
including triterpenoids, phenolic compounds, carotenoids, steroids and ketones. The extract 
of the neem leaves contains gedunin, nimbin, nimbolide and many more limonoids (Roy 
and Saraf, 2006).  
It has been identified for their in vitro antimalarial activity of gedunin, 
dihydrogedunin and nimbolide were found to be most effective against  P. falciparum 
sensitive strains. The study of antimalarial activity of the oil neem fruits which was given 
orally on mice showed that the effective dose 50 (ED50) which could inhibited the growth of 
P. berghei was 200 mg/kg of Body Weight (Mulyaningsih  and Sudarsono, 2001). Nimbolide 
is the most active compound which inhibited the P. falciparum K1(IC50 = 0,95 ng/ml), 
gedunin (IC50 = 720 ng/mL, P. falciparum D6) and its dihydro derivates were also found to 
be active in vitro (IC50 = 2630 ng/mL) ( Rochanakij et al, 1985, Mackinon et al, 1997). The 
aqueous extract (IC50 = 115 µg/ml) and ethanolic extract (IC50 = 5 µg/ml) (Rochanakij  et 
al., 1985).  
Neem is a traditional herb that has an exotic structure, mode of action and 
efficacious against chloroquine sensitive parasites. Neem leaves extract showing the 
highest activity against the chloroquine sensitive parasite, but there has not been any 
reports on its effect in chloroquin resistant parasite. The aim of this study was to find the 
antimalarial activity of the neem leaves extract on the growth stages of P. falciparum 
chloroquine resistant in vitro.  
This study acts to component which work in the blood stages of the malarial 
infection. In the future the components with acceptable criteria would be continued for in 
vivo efficacy test and after toxicity studies successful antimalarial candidate could be 
continued to clinical studies.   
 
Materials and Methods 
Materials 
Fresh neem leaves (A.indica A.Juss) were collected in Darussalam region Banda Aceh and 
were identified. P.falciparum FCR-3 was obtained from Laboratory of Parasitology Medical 
Faculty Gadjah Mada University. Red blood cells and human serum (O+), RPMI-1640 
(Sigma), giemsa 10% (Merck), sorbitol 5% (Merck), ethanol 96% (Merck), aqua bidestillata 
steril (KF), absolute methanol (Merck), gentamisin (Merck), dimetilsulfoxide (Merck), 
NaHCO3 (Merck), NaCl (Merck), immersion oil (Merck). 
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Instrument 
Incubator (370C), candle Jar (desiccator with CO2), culture flask, centrifuge, micropipet, 
microplate, blue and yellow tip, drying rack for blue and yellow tip, conical tube, eppendorf 
tube, object  glass and microscope. 
The preparation of neem leaves extract 
The fresh neem leaves were cut into small pieces and extracted three times for 24 hour 
with ethanol 80% (1 : 5). The solvent is replaced every 24 hour and the ethanolic solutions 
were evaporated at 400C under reduced pressure (Santos et al., 1978). The thick extracts 
subjected to the antimalarial in vitro test. 
Cultivation of P. falciparum and in vitro antimalarial activity test  
The steps of in vitro antimalarial activity covered: sterilization of all instruments and 
substances, preparation of normal erythrocite and human serum, medium culture for 
cultivation, thawing of P. falciparum, culture synchronized with sorbitol 5% and 
microculture for antimalarial activity test. 
Plasmodium falciparum FCR-3 (IC50 for chloroquin = 0,050 mM) were maintained in 
continuous culture in human red blood cells (O+) added 1% hematocrit in RPMI 1640. 
Medium supplemented with 25 nM HEPES, 30nM NaHCO3 and 10% Human O+ serum 
(Trager & Jensen, 1976). The ethanolic extracts were dissolved in dimethylsulfooxide 
(DMSO) to make a stock solution (1mg/ml) and diluted in medium (RPMI 1640) to final 
concentration. Before testing the extract in medium, sterilized by filtration (pore size = 
0,22um). Antimalarial activity were performed in 96 well microculture plates. Briefly, 100 
µL treated drugs were added to each well in microculture plate and 100 µL of paratized 
culture (haemotocrit 1%, 0,5% parasitaemia) were added to each well in microculture plate 
and incubated in CO2 candle jar for 72 hour at 37
0C (Trager & Jensen, 1976). Every 8 hour 
the percentage of parasitemia were measured for observing the activity of the extract on 
the growth stages of P. falciparum FCR-3. After incubation contents of the wells were 
harvested and stained. The growth stages of parasites was monitor by making a thin blood 
smear, fixed with methanol and stained with Giemsa 10% for 30 minutes. All test were 
performed in triplicate. 
 The parasitemia was examined under microscope with magnification 1000  by 
adding immersion oil.  Parasitemia was calculated by formula: 
 
% parasitemia = Number of infected red blood cells  X 100 
       Total red blood cells  
 
The percentage of the growth  inhibition of the parasites was calculated by formula: 
 
% inhibition = Parasitemia in control – parasitemia in treated group X 100% 
     Parasitemia in control 
 
The percentage of the growth stages inhibition of the parasites at each concentration was 
determined by the mean of at least three IC50 parasites viability. The fifty percent of growth 
stages inhibition was calculated using probit analysis. 
  
Results and Discussion 
The result of in vitro antimalarial activity of the extract of the neem leaves (A.indica A.Juss) 
on P.falciparum FCR-3 were obtained. The percentages of parasitemia and the percentages 
of growth stages inhibitory of P.falciaparum calculated in every 8 hour interval to 72 hour  
shown in the Tabel 1, 2 and Figure 1, 2.  
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Tabel 1. The percentage of parasitemia at different concentrations of neem leaves extract 
after cultivation in 8 hour interval to 72 hour 
 
Concentration 
(ug/mL) 
% Parasitemia 
Interval of cultivation (hour) 
8 16 24 32 40 48 56 64 72 
0,000 8,166 11,04 12,67 16,22 15,87 16,36 15,660 15,920 16,38 
3,125 6,128 8,011 8,040 9,510 11,53 11,20 14,790 13,61 11,21 
6,250 5,215 7,329 6,670 6,260 8,960 11,03 13,690 12,390 10.42 
12,500 5,039 7,021 5,590 5,770 7,120 10,71 13,020 12,170 9,090 
25,000 3,541 5,626 5,070 5,150 6,210 9,570 12,210 11,580 7,870 
50,000 2,566 5,300 4,670 4,670 5,080 6,770 10,500 10,220 6,040 
100,000 2,229 4,248 4,270 3,400 4,040 5,520 9,150 8,160 5,570 
200,000 1,701 3,027 3,690 2,610 3,350 3,790 4,090 5,010 3,920 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. The percentage of parasitemia at different concentrations of neem 
leaves extract after cultivation in 8 hour interval to 72 hour 
 
 
Tabel 2. The percentage of growth inhibition of P. falciparum at different concentrations  
of neem leaves extract after cultivation in 8 hour inteval to 72 hour. 
 
Concentration 
(ug/mL) 
% Growth Inhibition of P.falciparum 
Interval of cultivation (hour) 
8 16 24 32 40 48 56 64 72 
0,000 - - - - - - - - - 
3,125 24,96 27,44 36,54 41,38 27,35 31,54 5,56 14,51 31,56 
6,250 36,14 33,61 47,37 61,42 43,57 32,58 12,58 22,17 36,39 
12,500 38,29 36,40 55,88 64,40 55,77 34,53 16,86 23,56 44,50 
25,000 56,64 49,04 59,94 68,23 60,86 41,48 22,03 27,26 51,97 
50,000 68,58 51,99 63,14 71,19 68,02 58,61 32,95 35,80 63,16 
100,000 72,70 61,52 66,28 79,02 74,56 66,28 41,55 48,72 64,78 
200,000 79,17 72,58 70,86 89,83 78,88 76,81 73,84 68,56 76,06 
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Figure 2. The percentage of growth inhibition of P. falciparum at different  
concentrationsof neem leaves extract after cultivation in 8 hour inteval to 72 hour. 
 
Antimalarial activity was determined by fifty percent of growth stages inhibitory of P. 
falciparum (IC50). In this investigation we found each 8 hour interval to 72 hour are 
presented in Table 3 and Figure 3 which was calculated using probit analysis. 
 
Tabel 3. The IC50 value of neem leaves extract on the growth of P. falciparum 
after cultivation in 8 hour inteval to 72 hour. 
 
Observation (hour) IC50 (µg/mL) 
8 18,73 
16 31, 72 
24 9,77 
32 3,86 
40 12,08 
48 27,53 
56 99,30 
64 92,93 
72 19,42 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. The IC50 value of neem leaves extract on the growth of 
P. falciparum after cultivation in 8 hour inteval to 72 hour. 
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Discussion 
Determining of antimalarial activity based on the fifty percent of growth inhibitory (IC50) of 
treated extract. The IC50 is the concentration of crude treated drug which inhibite the 
growth of Plasmodium until fifty percent. In vitro antimalarial activity could be categorized 
as follow as the value of  IC50.  In this investigation the most interesting in vitro antimalarial 
activity was found in the concentration inhibition 50 (IC50 = 3,86 µg/mL) of the ethanolic 
extract of neem leaves on mature schizont stage, but Alshawsh et al, (2007)  was found 
the concentration inhibition 50 (IC50 = 2, µg/mL) of the aqueous of the neem leaves 
extract.  
In this investigation we found the most potent in vitro antimalarial activity  IC50 = 
3,86 µg/ml <  10 µg/ml at 32 hour. Miscrospically, the fifty percent of growth P. falciparum 
inhibition on mature schizont in value 81,66%  and on young tropozoit 18,34% after 32 
hour cultivation.   
The IC50 which found in these investigation were different to the previous reseacher 
(IC50 of ethanolic extract of neem leaves = 5 µg/ml). The condition may be caused by the 
coumpound in the leaves (Munoz et al., 2000). As we known the in vitro antimalarial 
activity was not described as the in vivo antimalarial activity, such a thing resulted in the 
differences of its metabolic agent.  
 
Conclusions 
The result showed that neem leaves extract has in vitro antimalarial activity on P. 
falciparum FCR-3 with IC50 3, 86 µg/ml. The IC50 categorized as the most potential 
antimalarial activity after 32 hour cultivation. The percentage of growth inhibitory is 
81,66% on mature schizont and on young tropozoit 18,34% after 32 hour cultivation.   
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